These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 344094)

  • 1. Enhancement of the antibody response in vitro by BCG.
    Brown CA; Brown IN; Sljivíc VS
    Dev Biol Stand; 1977 Apr 13-15; 38():153-8. PubMed ID: 344094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1980 Jul; 40(3):303-9. PubMed ID: 6448801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1979 Nov; 38(3):481-8. PubMed ID: 391696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further studies on the enhancement of the antibody response in vitro by C. parvum.
    Slijivíc VS; Brown CA; Watson SR
    Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of humoral immune responses. I. Potentiating influence of purified protein derivative on the invitro immune response of spleen cells sensitized to Mycobacterium bovis and Mycobacterium avium.
    Muscoplat CC; Setcavage TM; Thoen CO; Kim YB
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):266-72. PubMed ID: 797671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
    Teruya K; Kawakami K; Tohyama M; Saito A
    Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro.
    Brown CA; Brown IN; Sljivić VS
    Immunology; 1981 Jan; 42(1):67-73. PubMed ID: 7007221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of immunopotentiating action of BCG: persistence and spread of BCG infection.
    Ishibashi T; Harada Y; Harada S; Yamada H; Takamoto M; Sugiyama K
    Jpn J Exp Med; 1978 Jun; 48(3):227-32. PubMed ID: 362025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting effects of BCG on spleen and lymph node antibody responses in nude and normal mice.
    Doft BH; Merchant B; Johannessen L; Chaparas SD; Sher NA
    J Immunol; 1976 Nov; 117(5 Pt 1):1638-43. PubMed ID: 1087322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of BCG on the production of antibody-forming cells in the primary and secondary immune response against sheep erythrocytes in the mouse].
    Gryschek G
    Acta Biol Med Ger; 1975; 34(1):155-61. PubMed ID: 1101593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intensification of spontaneous plaque formation by BCG-sensitized mouse spleen cells under the influence of tuberculin in vitro].
    Morozov VL; Ivakova TR
    Patol Fiziol Eksp Ter; 1979; (6):52-4. PubMed ID: 396508
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the mode of immunopotentiating action of BCG and wax D. I. Effect on the immune response to SRBC.
    Ishibashi T; Harada Y; Yamada H; Harada S; Takamoto M
    Jpn J Exp Med; 1977 Jun; 47(3):163-8. PubMed ID: 410972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza A2 inhibits murine in vitro antibody synthesis.
    Daniels CA; Marbrook J
    J Immunol; 1981 May; 126(5):1737-41. PubMed ID: 6971313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression and enhancement of the T cell-dependent production of antibody to SRBC in vitro by bacterial lipopolysaccharide.
    Hoffmann MK; Weiss O; Koenig S; Hirst JA; Oettgen HF
    J Immunol; 1975 Feb; 114(2 pt 2):738-41. PubMed ID: 1089715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice.
    Matsumura H; Nakano M
    J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Suppressive effect of xenogenic bone marrow cells on antibody formation in a spleen cell culture in vitro].
    Vlasov AA; Sidorovich IG; Khaitov RM
    Biull Eksp Biol Med; 1980 Jul; 89(7):77-9. PubMed ID: 7407376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age and features of the suppressor activity of antigen primed spleen cells of CBA strain mice and regulation of the immune response in old age].
    Andrianova LF
    Ontogenez; 1978; 9(4):411-6. PubMed ID: 692981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
    Bonventre PF; Straus D; Baughn RE; Imhoff J
    J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative and positive immunobiological responses in mice pretreated with Bacillus Calmette-Guérin cell wall.
    Mizushima Y; Wepsic HT; Yamamura Y; DeSilva MA; Janns G; Larson CH
    Cancer Res; 1984 Jan; 44(1):20-4. PubMed ID: 6228292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.